The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart Failure
Authors:
- 8 March 1996
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 36 (3) , 257-264
Abstract
The effect of epoprostenol on the pharmacokinetics of furosemide was investigated in 23 patients with end‐stage congestive heart failure (CHF) receiving conventional therapy alone or conventional therapy plus epoprostenol. Estimates of the apparent oral clearance, volume of distribution, and absorption rate constant for furosemide were generated from 198 serum furosemide concentrations using nonlinear mixed effects modeling (NONMEM). Univariate analyses were performed to assess the effects of patient factors on the apparent oral clearance of furosemide. The final multivariate model determined by backwards elimination included concomitant digoxin therapy. When concomitant epoprostenol therapy was included in the final model, there was a 13% decrease in the apparent oral clearance of furosemide in response to short‐term administration of epoprostenol. However, the effect of concomitant epoprostenol therapy was not statistically significant and was no longer apparent by the end of the 12‐week study. These data suggest that epoprostenol may have a slight short‐term effect on the pharmacokinetics of furosemide; the interaction between epoprostenol and furosemide is not clinically significant, however.Keywords
This publication has 19 references indexed in Scilit:
- The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart FailureThe Journal of Clinical Pharmacology, 1996
- The Effects of Epoprostenol on Drug Disposition I: A Pilot Study of the Pharmacokinetics of Digoxin with and without Epoprostenol in Patients with Congestive Heart FailureThe Journal of Clinical Pharmacology, 1996
- Safety and efficacy of epoprostenol in patients with severe congestive heart failureThe American Journal of Cardiology, 1995
- Absorption of High Dose Furosemide (Frusemide) in Congestive Heart FailureClinical Pharmacokinetics, 1992
- Pharmacostatistical modeling for observational dataJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Furosemide (Frusemide)Clinical Pharmacokinetics, 1990
- Furosemide pharmacokinetics and pharmacodynamics in health and disease—An updateJournal of Pharmacokinetics and Biopharmaceutics, 1989
- Prostacyclin Selectively Enhances Blood Flow in Areas of the GI Tract Prone to Stress Ulceration1984
- The renin - kallikrein - prostaglandin system: Plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in manProstaglandins and Medicine, 1980
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976